Cencora cash flow statement
In fiscal 2025, Cencora's operations generated $3.88bn of cash; it spent $668m on capital projects, leaving free cash flow of $3.21bn. It returned $437m in dividends and $435m through buybacks.
Cash flow statement
| Fiscal year | 2009Sept 2009 | 2010Sept 2010 | 2011Sept 2011 | 2012Sept 2012 | 2013Sept 2013 | 2014Sept 2014 | 2015Sept 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 784 | 1,109 | 1,168 | 1,305 | 788 | 1,465 | 3,922 | 3,178 | 1,504 | 1,411 | 2,344 | 2,207 | 2,667 | 2,703 | 3,911 | 3,485 | 3,875 | 4,821 |
| Depreciation and amortisation | 75 | 84 | 101 | 134 | 162 | 189 | 249 | 365 | 398 | 465 | 462 | 391 | 505 | 694 | 964 | 1,092 | 1,051 | 1,038 |
| Stock-based pay | 27 | 30 | 27 | 26 | 36 | 43 | 61 | 65 | 62 | 62 | 59 | 74 | 100 | 93 | 125 | 148 | 148 | 149 |
| Capital spending | 146 | 176 | 156 | 133 | 202 | 264 | 232 | 465 | 466 | 336 | 310 | 370 | 438 | 496 | 458 | 487 | 668 | 761 |
| Free cash flow | 638 | 932 | 1,012 | 1,172 | 586 | 1,200 | 3,691 | 2,714 | 1,038 | 1,075 | 2,034 | 1,837 | 2,228 | 2,207 | 3,453 | 2,998 | 3,207 | 4,060 |
| Free cash flow after stock pay | 611 | 902 | 985 | 1,146 | 549 | 1,157 | 3,630 | 2,649 | 976 | 1,013 | 1,975 | 1,763 | 2,129 | 2,113 | 3,328 | 2,850 | 3,059 | 3,911 |
| Dividends paid | 63 | 91 | 118 | 133 | 196 | 214 | 254 | 288 | 320 | 333 | 339 | 344 | 367 | 392 | 399 | 416 | 437 | 468 |
| Share buybacks | 450 | 470 | 841 | 1,162 | 484 | 754 | 1,859 | 2,266 | 330 | 639 | 674 | 420 | 82 | 484 | 1,181 | 1,491 | 435 | 1,000 |
| Shares issued | — | — | — | — | — | — | — | — | — | 0 | 0 | 66 | 0 | 0 | — | — | — | — |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,000 | −2,719 | 3,351 | 109 | 3,133 | −2,305 | 1,339 | 2,654 |
| Depreciation and amortisation | 755 | 278 | 260 | 254 | 259 | 260 | 249 | 269 |
| Stock-based pay | 35 | 70 | 28 | 23 | 26 | 66 | 28 | 29 |
| Capital spending | 182 | 106 | 129 | 183 | 250 | 119 | 166 | 226 |
| Free cash flow | 818 | −2,825 | 3,222 | −74 | 2,884 | −2,425 | 1,173 | 2,428 |
| Free cash flow after stock pay | 783 | −2,895 | 3,194 | −97 | 2,858 | −2,491 | 1,145 | 2,399 |
Compare with peers
- McKesson cash flow
- Henry Schein cash flow
- 111, Inc. cash flow
- Cosmos Health Inc. cash flow
- Cellyan Biotechnology Co., Ltd cash flow
Head to head: COR vs MCKCOR vs HSICCOR vs YI
More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies